ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,216, issued on Oct. 6, was assigned to AROA BIOSURGERY Ltd. (Auckland, New Zealand). "Bioactive agents and methods related thereto" was inve... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,217, issued on Oct. 6, was assigned to Universite de Lille (Lille, France) and University of Dundee (Dundee, Great Britain). "IL-10 muteins"... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,218, issued on Oct. 6, was assigned to The Trustees of the University of Pennsylvania (Philadelphia). "Dual CAR expressing T cells individua... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,219, issued on Oct. 6, was assigned to City of Hope (Duarte, Calif.). "CCR4 targeted chimeric antigen receptor modified T cells for treatmen... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,220, issued on Oct. 6, was assigned to Cellectis (Paris). "Mesothelin specific chimeric antigen receptors (CAR) for solid tumors cancer immu... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,221, issued on Oct. 6, was assigned to AbelZeta Inc. (Rockville, Md.). "Combined chimeric antigen receptor targeting CD19 and CD20 and appli... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,222, issued on Oct. 6, was assigned to OMNIOX INC. (San Carlos, Calif.). "Polymeric forms of H-NOX proteins" was invented by Gregory Kapp (S... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,223, issued on Oct. 6, was assigned to AC Immune SA (Lausanne, Switzerland). "Antibodies binding to alpha-synuclein for therapy and diagnosi... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,224, issued on Oct. 6, was assigned to Ablynx NV (Zwijnaarde, Belgium) and Merck Patent GmbH (Darmstadt, Germany). "Aggrecan binding immunog... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,225, issued on Oct. 6, was assigned to Alector LLC (South San Francisco, Calif.). "Anti-MS4A4A antibodies and methods of use thereof" was in... Read More